Log in to save to my catalogue

The administration of antisense oligonucleotide golodirsen reduces pathological regeneration in pati...

The administration of antisense oligonucleotide golodirsen reduces pathological regeneration in pati...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0bb99a8919a34521a7b32c5a0a245087

The administration of antisense oligonucleotide golodirsen reduces pathological regeneration in patients with Duchenne muscular dystrophy

About this item

Full title

The administration of antisense oligonucleotide golodirsen reduces pathological regeneration in patients with Duchenne muscular dystrophy

Publisher

England: BioMed Central

Journal title

Acta neuropathologica communications, 2021-01, Vol.9 (1), p.7-7, Article 7

Language

English

Formats

Publication information

Publisher

England: BioMed Central

More information

Scope and Contents

Contents

During the last decade, multiple clinical trials for Duchenne muscular dystrophy (DMD) have focused on the induction of dystrophin expression using different strategies. Many of these trials have reported a clear increase in dystrophin protein following treatment. However, the low levels of the induced dystrophin protein have raised questions on it...

Alternative Titles

Full title

The administration of antisense oligonucleotide golodirsen reduces pathological regeneration in patients with Duchenne muscular dystrophy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_0bb99a8919a34521a7b32c5a0a245087

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0bb99a8919a34521a7b32c5a0a245087

Other Identifiers

ISSN

2051-5960

E-ISSN

2051-5960

DOI

10.1186/s40478-020-01106-1

How to access this item